Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction
Clinical trial NCT07538336 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07538336
- Sponsor
- University of California, San Francisco
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-02
- Primary completion
- 2028-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.